GC and neoplasm: Preliminary experiments conducted to xenograft, either i.p. or subcutaneously, the HTLV-1-immortalized C91/PL cell line at different doses (from 2 to 10 × 106 cells per mouse) in immunodeficient adult Rag2-/-γc-/- mice did not lead to tumor development (data not shown).